BUDESONIDE; FORMOTEROL FUMARATE | N216579 | ASTRAZENECA PHARMACEUTICALS LP
AstraZeneca gained new drug substance exclusivity for Symbicort AeroSphere (budesonide/formoterol fumarate) under NDA 216579.
New: New record
AstraZeneca added U.S. Patent 10,716,753 to the Orange Book for Symbicort AeroSphere (budesonide/formoterol fumarate) NDA 216,579.
New: New record
AstraZeneca added U.S. Patent 9,415,009 to the Orange Book for Symbicort Aerosphere (budesonide/formoterol fumarate).
New: New record
AstraZeneca added a new regulatory exclusivity designation (I-988) to the Orange Book for Symbicort Aerosphere (budesonide/formoterol fumarate), NDA 216579.
New: New record